13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-12, with 62 holding rows worth $188,660,000.
- Accession
- 0001387131-21-002218
- Filer
- CIK 1773195
- Filed
- 2021-02-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 62 entries on the cover page, a total value of $188,660,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $188,660,000 with VALUE read as thousands by filing date, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 225,000 | $29,606,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 40,000 | $14,955,000 | thousands by filing date | put |
| CURIS INC | 231269200 | COM | 1,450,000 | $11,876,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 155,000 | $11,022,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 260,000 | $8,492,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 403,000 | $8,427,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 105,000 | $5,758,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 45,000 | $5,757,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 220,000 | $4,554,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 270,000 | $4,477,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 200,000 | $4,342,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 4,000,000 | $4,035,000 | thousands by filing date | principal |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 40,000 | $3,730,000 | thousands by filing date | put |
| IMMUNOVANT INC | 45258J102 | COM | 75,000 | $3,464,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 150,500 | $3,347,000 | thousands by filing date | call |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 45,000 | $3,292,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITION CO | G3166W106 | COM CL A | 300,000 | $3,255,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 300,000 | $3,201,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 65,000 | $3,072,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 200,000 | $2,562,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 150,000 | $2,379,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 10,000 | $2,363,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 67,500 | $2,265,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 625,000 | $2,238,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 200,000 | $2,212,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 10,000 | $2,196,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 50,000 | $2,166,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 25,000 | $2,037,000 | thousands by filing date | call |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 904,600 | $2,035,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 250,000 | $1,895,000 | thousands by filing date | call |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 10,000 | $1,668,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 100,000 | $1,514,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP | 543195101 | COM CL A | 75,000 | $1,484,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 70,000 | $1,455,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 20,000 | $1,380,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 50,000 | $1,331,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 75,000 | $1,314,000 | thousands by filing date | |
| PANDION THERAPEUTICS INC | 698340106 | COM | 80,000 | $1,188,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 100,000 | $1,144,000 | thousands by filing date | |
| VESPER HEALTHCARE ACQSTN COR | 92538T104 | COM CL A | 100,000 | $1,131,000 | thousands by filing date | |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 117,545 | $918,000 | thousands by filing date | |
| BEYONDSPRING INC | G10830100 | SHS | 75,000 | $915,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 19,600 | $909,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 40,000 | $881,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 10,000 | $873,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 45,000 | $855,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 10,000 | $815,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 30,000 | $797,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T107 | COM | 75,000 | $794,000 | thousands by filing date | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 242,855 | $699,000 | thousands by filing date | |
| SIO GENE THERAPIES INC | 829399104 | COM | 250,000 | $695,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 100,000 | $686,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 20,000 | $663,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L114 | *W EXP 12/24/202 | 190,000 | $627,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 50,000 | $570,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 10,000 | $568,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 5,000 | $556,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 3,500 | $536,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 72,466 | $409,000 | thousands by filing date | |
| VAXART INC NEW | 92243A200 | COM | 25,000 | $143,000 | thousands by filing date | put |
| VESPER HEALTHCARE ACQSTN COR | 92538T112 | *W EXP 09/30/202 | 33,333 | $88,000 | thousands by filing date | |
| ZYNERBA PHARMACEUTICALS INC | 98986X109 | COM | 13,285 | $44,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-21-002218 | this filing | 2021-02-12 | acceptance time not in the bulk data set |